GRI Bio Presents Data Supporting Innovative Pipeline of NKT
Data presented at the 7th Annual Antifibrotic Drug Development (AFDD) Summit Company’s lead program, GRI-0621, has demonstrated ability to inhibit the...
Source: globenewswire.com
📰 Subsets Plays News
Subsets Plays News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Subsets Plays. Real-time updates on events, politics, business and more.
GRI Bio Presents Translational Data Demonstrating
Findings demonstrate that the number of NKT cells positively correlates with the number of airway macrophages in IPF patients GRI...
Source: globenewswire.com
GRI Bio (NASDAQ: GRI) Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Rapidly advancing clinical pipeline across multiple high-value inflammatory, fibrotic and autoimmune diseasesOn track to launch a Phase 2a biomark...
Source: businessinsider.com